Stem Cell Transplantation

Overview

Stem cell transplantation is a medical procedure in which healthy stem cells are infused into a patient to replace cells that are damaged, diseased, or destroyed. It is most established as hematopoietic stem cell transplantation, used to restore blood and immune-cell production in patients with blood cancers such as leukemia and lymphoma, bone marrow failure, and certain genetic and immune disorders. Transplants may be autologous, using the patient's own previously collected cells, or allogeneic, using cells from a matched donor, in which case the compatibility of human leukocyte antigens (HLA) is critical to reducing the risk of graft rejection and graft-versus-host disease. Successful transplantation depends on adequate mobilization and collection of stem cells, careful donor matching, conditioning regimens, and supportive care, including nutritional management during recovery. Research relevant to stem cell transplantation in the journal's record includes studies of allogeneic hematopoietic transplantation across HLA-mismatched donors and in the presence of donor-specific antibodies, immune thrombocytopenia following allogeneic transplantation, the role of HLA-DRB1 mismatch on outcomes, rescue mobilization of peripheral blood stem cells, a nutrition feeding algorithm for children undergoing transplantation, and biocompatible scaffolds for pluripotent stem cell transplantation. This page gathers peer-reviewed, open-access research relevant to stem cell transplantation.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 12 articles above have been cited 10 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

• Resolutive Treatment of Actinic Keratosis through Peptides Extracted from Zebrafish Conveyed Across Laser-assisted Transcutaneous Delivery (Cryopass Therapy)
  2025 · Current Medicinal Chemistry
• Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
  2023 · Frontiers in Immunology
• Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
  R. Bailén et al. · 2023 · Frontiers in Immunology
• Evaluation of Eltrombopag in Thrombocytopenia Post Hematopoietic Cell Transplantation
  2022 · Hematology/Oncology and Stem Cell Therapy
• Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
  2021 · Frontiers in Immunology
• Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
  R. Bailén et al. · 2021 · Frontiers in Immunology
• Evaluation of eltrombopag in thrombocytopenia post Hematopoietic cell transplantation: Rertrospective observational trial
  2020 · Hematology/Oncology and Stem Cell Therapy
• Successful Allogeneic Hematopoietic Stem Cell Transplantation from A 5/10 Mismatched Unrelated Donor in A Patient with Donor-Specific Anti-HLA Antibodies.
  2018 · Journal of Hematology and Oncology Research

A sample of recent works citing this journal's research on Stem Cell Transplantation, linking to each citing work.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics